Peptide Field Book

Reading settings

Choose a comfortable text size and appearance. Your choices are saved on this device.

Epitalon

Taken for longevity and sleep

Epithalon; synthetic epithalamin

Match every finding to its exact substance, formulation, route and study population. A related molecule or approved medicine does not validate a catalog vial.

Animal / laboratory evidence
AEDG
Schematic illustration · View structure evidenceAEDG
Color key
NonpolarAromaticPositive chargeNegative chargePolar Copper ion D-form or non-natural

At a glance

Why people take it. And what backs it up.

  1. Slow aging

    Animal studies only

    Many take 10-day courses once or twice a year hoping to slow aging; most of the research comes from its developers.

    Sources (5)
  2. Sleep better

    Sleep untested; melatonin rose in one study

    Others take small bedtime doses to sleep better and reset a disrupted body clock.

    Sources (3)
  3. Look and feel younger

    People report it, not studied

    Users also take it for better skin and more energy, and clinics market it for younger-looking skin.

    Sources (2)

Evidence briefing

Sources checked

What the sources support.

Epitalon (epithalon) is the tetrapeptide Ala-Glu-Asp-Gly, synthesized to model aspects of pineal epithalamin. The often-cited telomerase result was in human fetal fibroblast culture, not a study treating people. FDA staff recommended against listing epitalon forms for compounding, but the July 2026 PCAC committee recommended inclusion; this nonbinding vote is not an FDA drug approval or final bulks-list decision. No approved longevity treatment was identified.

Keep in mind

Cellular telomerase findings do not establish telomere change, lifespan extension, clinical efficacy or safety in humans; the 503A vote relates to compounding policy, not FDA review of an approved product.

Identity and research status reviewRead the original sources

The research. What’s been studied.

From animal and lab studies

  • Telomerase in cell culture

    One study reported telomerase activity and telomere elongation in cultured human fetal fibroblasts; this does not demonstrate the same effect in people.

  • Melatonin-rhythm research

    Changes in melatonin rhythms have been reported in older animals; clinical benefit in people is not established.

  • Rodent lifespan research

    Some developer-group rodent studies reported lifespan effects. They do not show that epitalon extends human lifespan.

What do these labels mean?
  • Human evidence: approved-drug data or larger human studies, within the populations and uses studied.
  • Early human studies: small, preliminary or limited human studies.
  • Animal & lab studies: animal or laboratory findings that do not establish effects in people.
  • Unverified: a proposed use or claim without verified supporting clinical evidence.
How each claim was reviewed (3)

Reported effects and evidence.

A citation may support, qualify or correct a claim. Read the study scope; a laboratory result is not an established benefit in people. Each review covers a claim as it was first collected; the tiles above show the collection’s current wording.

  1. In-vitro human-cell experiment

    Review of “Telomere support”

    Epitalon increased telomerase-related activity/telomere measures in cultured human cells.

    Limitations and applicability. Human cells in culture are not human treatment evidence; avoid implied lifespan or safety benefit.

    Original collected claim and review history

    Original title: Telomere support

    Activated telomerase and lengthened telomeres in human cells in the lab.

    Original label: animal. Preserved for traceability; the reviewed wording above qualifies this record.

    Record epitalon:benefit:1 · Annotated 2026-10-01 · Review method

  2. Preclinical aged-monkey study

    Review of “Sleep rhythm”

    An old-monkey study reported altered melatonin/cortisol rhythms; clinical sleep benefits remain unestablished.

    Limitations and applicability. Study concerns melatonin/cortisol measures, not demonstrated improvement in sleep.

    Original collected claim and review history

    Original title: Sleep rhythm

    Restored melatonin rhythms in older animals.

    Original label: animal. Preserved for traceability; the reviewed wording above qualifies this record.

    Record epitalon:benefit:2 · Annotated 2026-10-01 · Review method

  3. Preclinical rodent survival experiments

    Review of “Longer lifespan in rodents”

    Specific rodent studies from the developer-associated group reported survival effects; human lifespan extension is unestablished.

    Limitations and applicability. Effects depend on strain, controls and survival analysis. Keep developer-group attribution and no human extrapolation.

    Original collected claim and review history

    Original title: Longer lifespan in rodents

    Rodent studies from the developer’s group reported longer lifespans.

    Original label: animal. Preserved for traceability; the reviewed wording above qualifies this record.

    Record epitalon:benefit:3 · Annotated 2026-10-01 · Review method

The research in detail

Evidence category

Mostly animal and cell studies

The commonly cited telomerase finding came from cultured human fetal fibroblasts; rodent work also exists. These results do not show lifespan extension or clinical benefit in people. In July 2026 the PCAC committee recommended epitalon for possible 503A list inclusion, contrary to FDA staff’s recommendation; the vote is nonbinding and does not approve a drug.

Evidence is assessed claim by claim above. Regulatory approval, study design, findings and relevance are separate questions; there is no single evidence score.

Risks and unknowns. What to know first.

Collected cautions follow. These are not an exhaustive or independently validated safety assessment; claim references do not automatically support every caution.

  • Little safety data.
  • Telomerase activation is a theoretical cancer concern, since cancer cells rely on it to keep dividing.

What people report

Show all 13 cautionsShow fewer cautions

Read this first: what “research use only” means

Published dosing records. What the trials used.

Historical label and trial records for the named product, route, population and indication. These records are not a personal schedule or a validated regimen for a catalog vial. Source attribution does not establish applicability.

Under-tongue study

Small randomized, placebo-controlled study in middle-aged women who worked night shifts and had low melatonin output (Advances in Gerontology, 2020, in Russian)

Fixed courseClinical trial

Source: Ivko et al., Uspekhi Gerontologii (Advances in Gerontology), 2020 (opens in a new tab)

Days 1–20 (total per day)
0.5 mg
How
Spray under the tongue
How often
Twice a day (morning and midday, before meals), 3 sprays each time
How long
20 days in the study
  • This was a spray under the tongue, not an injection. No injected dose has been established.
  • The 0.5 mg is the total for each day; the paper does not state the amount per spray.
  • The spray was a dietary-supplement product (Epitalon Solution-Spray, Nanopep, France).
  • Forty women were split at random into two equal groups: peptide spray or saltwater spray.
  • The study measured a melatonin breakdown product in urine and clock-gene activity in blood cells, not health outcomes.

These doses were tested in clinical trials under medical supervision. They aren’t approved for use, and a research vial is not the product that was tested.

Community protocols. Reported online. Not clinically validated.

Community reports Collection date: 30 Sep 2026

The most common protocol is a short course of 5–10 mg a day (often 10 mg a day for 10 days) injected under the skin, repeated once or twice a year.

More about this

A large second camp uses 100–500 mcg a day (some up to 1 mg) for sleep, often for longer; doses in circulation differ about 100-fold, and sprays, drops and capsules are also used.

Not testedFrequently encountered in reviewed sources

Short daily course (“Khavinson protocol”)

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
5–10 mg a day (the most repeated version is 10 mg a day)
How often
Once a day, or split into two injections (morning and late afternoon)
Route
Injection under the skin; some inject into a muscle, as in the Russian studies
Timing
Often at bedtime; others split it morning and late afternoon
How long
10–20 days (about 100 mg per course; 10 mg × 10 days or 5 mg × 20 days)
Cycle
Repeated once or twice a year, usually 4–6 months apart
Mixing
Depends on vial size (10–50 mg vials are sold); for example, a 50 mg vial with 3 mL water gives 5 mg in 0.3 mL (30 units)
  • 10 mg a day for 10 days, twice a year, is the version most often called the Khavinson or “Russian” protocol; 5 mg a day for 20 days is the common alternative.
  • Clinic websites reviewed by the FDA gave 5–10 mg a day, used in cycles; one recommended a course every 4 months.
  • Many forum users now argue these doses are far too high for synthetic epitalon (see the low-dose protocol and flags).
Sources (4)

Not testedCommon

Low daily dose (“microdose”) for sleep

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
100–500 mcg a day (some go up to 1 mg)
How often
Once a day
Route
Injection under the skin
Timing
Disputed: some inject 1–2 hours before bed, but many switch to the morning or late afternoon because evening doses keep them awake
How long
Usually 10–20 days; some run it for 1–3 months or longer
Cycle
Varies: 10–20 day courses 2–3 times a year, or 5 days on and 2 off for months (see also the monthly 10-day cycle)
Ramp
Some start at 100 mcg and step up by about 100 mcg a week
Mixing
A 10 mg vial with 1 mL bacteriostatic water gives 100 mcg per insulin-syringe unit
  • Backers say the 10 mg “Khavinson” dose was for epithalamin (a calf pineal-gland extract), not synthetic epitalon, which they say is about 100 times stronger. That potency figure is repeated widely but not verified.
  • A compounding pharmacy chart (Tailor Made Compounding) lists a 3,000 mcg/mL vial at 0.1 mL a day, which is 300 mcg a day; the same chart row lists tendon repair as the use, which looks like a copy error.
  • Dr. Craig Koniver’s clinic says it used a low bedtime dose for circadian rhythm, often with pinealon and selank, but gives no amount.
  • Reports conflict: some users feel nothing at microdoses and move up to 5–10 mg; others say only low doses improve their sleep.
Sources (4)
Show all 10 protocolsShow fewer protocols

Not testedSometimes seen

Every-third-day course (“Ukrainian protocol”)

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
10 mg per injection (50 mg per course)
How often
Every third day (one version: every fourth day, on days 1, 5, 9, 13 and 17)
Route
Injection under the skin or into a muscle
How long
About 15–17 days (5 injections)
Cycle
Twice a year (about every 6 months)
Mixing
The Tailor Made Compounding pharmacy sold it ready-mixed at 10 mg/mL in a 5 mL vial
  • A US compounding pharmacy’s peptide catalog (Tailor Made Compounding, Kentucky) listed this as its suggested dosage.
  • The name “Ukrainian protocol” is used inconsistently: some forum users apply it to 5 mg a day for 20 days instead.
Sources (4)

Not testedSometimes seen

Monthly 10-day microdose cycle

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
100 mcg (0.1 mg) a day
How often
Once a day
Route
Injection under the skin
How long
10 days, then 20 days off
Cycle
Every month, indefinitely
Mixing
A 10 mg vial with 1 mL bacteriostatic water gives 100 mcg per insulin-syringe unit
  • Promoted by a Reddit user, from their own experiments, as avoiding the tolerance and sleep problems they had at larger doses; others now repeat it as the “normal protocol”.
Sources (3)

Not testedSometimes seen

1 mg every evening, long term

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
1 mg (10 units of a 10 mg/mL solution)
How often
Once a day
Route
Injection under the skin
Timing
In the evening
How long
Long term, with occasional breaks; variants run 1 mg for 20 days every 3 months, or on weekdays only
Mixing
10 mg/mL solution (10 units = 1 mg)
  • Attributed to Dr. Heather Smith-Fernandez on Dave Asprey’s podcast; the transcript’s show notes convert her 10 units to 1 mg.
  • A European peptide seller posting on Reddit said it recommends 1 mg daily to its customers.
Sources (4)

Not testedSometimes seen

Under-the-tongue spray (commercial product)

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
0.5 mg a day (6 sprays of about 83 mcg)
How often
Twice a day (3 sprays each time)
Route
Under the tongue (sublingual spray)
Timing
Before meals, morning and afternoon
How long
20 days
Cycle
Repeat every 4–6 months
Mixing
Ready-made spray
  • This matches a 2021 Russian study in night-shift workers that used this spray at 0.5 mg a day for 20 days.
  • Other sellers’ sprays are stronger (for example 200–400 mcg per spray), so spray counts are not comparable between products.
Sources (2)

Not testedSometimes seen

Nasal spray

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
Usually about 100 mcg–1 mg a day; one forum user used 3 mg twice a day
How often
Once or twice a day (1–2 sprays for ready-made products)
Route
Nasal spray (ready-made or homemade from vials)
Timing
Usually 30 minutes to 2 hours before bed
How long
10 days to about 50 days
Cycle
For example 10 days a month or 10 days a quarter
Mixing
One ready-made spray is 10 mg in 10 mL, about 100 doses
  • Spray strength varies by product (about 100 mcg to 400 mcg per spray), so spray counts are not comparable.
  • The modified form N-acetyl epitalon amidate is often sold for nasal use.
Sources (4)

Not testedSometimes seen

Oral capsules

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
Capsules of 1–3.3 mg; reports range from 1–2 mg a day to a claimed 10 mg a day
How often
Once or twice a day
Route
Oral (swallowed capsules, sometimes enteric-coated)
How long
For example 21-day courses
Cycle
One user took a 1-week break between courses
  • Several research-peptide sellers sell 3 mg or 3.3 mg capsules; some add an absorption enhancer (sodium caprate).
  • Many forum users doubt a swallowed peptide is absorbed; one claim is that oral use needs 10 mg a day versus 100 mcg injected.
  • Peptide Sciences, a large US research-peptide seller, began selling enteric-coated epitalon capsules around 2023.
Sources (4)

Not testedSometimes seen

Homemade under-the-tongue drops (older forum practice)

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
1–3 mg a day (a few used up to 5 mg)
How often
Once a day
Route
Under the tongue (drops)
Timing
Usually at bedtime
How long
Weeks to months
Cycle
For example 3–4 weeks on, then 1–2 weeks off; some took it continuously
Mixing
Powder dissolved in distilled water with a little alcohol (vodka or wine, about 5–7%), kept in the fridge
  • Mainly Longecity users in about 2011–2016, dosing group-buy bulk powder by the drop or using pre-dosed sublingual products; some ran 21-day courses with 1-week breaks.
Sources (4)

Not testedFringe

Very high daily dose

Collected report · exact form and route are only as reported below. Source date and reporter identity are not separately verified. Collection checked 30 Sep 2026; presentation annotated 2026-10-01.

Frequency labels describe this collection, not a measured population. Contradictory records remain available.

Details and sourcesHide details
Dose
15–20 mg a day
How often
Once a day, or 3 times a day
Route
Injection under the skin
How long
About 1–2 weeks
Ramp
One user built up to 15 mg a day gradually
Mixing
One testimonial: 15 mg vial in 2.1 mL bacteriostatic water, 70 units (about 5 mg) per injection
  • Scattered individual reports only; one user who reached 15 mg a day felt unwell (see cautions).
Sources (3)

Where the numbers come from

The popular “Khavinson protocol” (10 mg a day into a muscle for 10 days, 100 mg per course, twice a year) comes from Russian studies of epithalamin, a calf pineal-gland extract, not synthetic epitalon: Khavinson and Morozov (2002) gave epithalamin and thymalin at 10 mg a day into a muscle for 10 days. The every-third-day version (10 mg every 3 days, 50 mg per course) is attributed by practitioners to the Kyiv (Ukrainian) epithalamin studies; the Tailor Made catalog cites one of them (Korkushko et al., 2011). Books (William Seeds, Peptide Protocols), the International Peptide Society and biohacking blogs (Ben Greenfield, 2017) carried these numbers over to synthetic epitalon, and a US compounding pharmacy sold 10 mg/mL and 3,000 mcg/mL vials, matching the two products later nominated to the FDA. The microdose camp scales down from a monkey study of synthetic epitalon (10 mcg per animal a day into a muscle; about 2 mcg/kg by forum estimates). The sublingual spray copies a 2021 study (0.5 mg a day for 20 days).

Home-made sprays and serums

Home-made nasal spray. Community recipes. Not tested.

Original source recordsHide

Epitalon is sold ready-made as a nasal spray (for example 10 mg in 10 mL), and a few users make their own; common use is 1–2 sprays at night, though some say mornings are better for sleep. Community only; the only intranasal research is in rats.

Best evidence: Rat studies of intranasal epitalon (Russia, 2006–2007). Otherwise community only (Reddit, 2023–2026).

Not testedNasal spraySometimes seen

Ready-made vendor spray, 10 mg in 10 mL

Original source-specific report. Collection checked 30 Sep 2026; presentation annotated 2026-10-01. Source date and reporter identity are not separately verified. Exact form and route are limited to the source’s description.

Batch: 10 mL

Ingredients and methodHide the recipe

Ingredients

IngredientAmountRole
Epitalon10 mgActive
How it’s used
Suggested 2 sprays at night; another user takes 1 spray per nostril about 2 hours before bed; another says mornings work better, as evening use can make it harder to fall asleep.
  • One user made an epitalon spray at home for their father, alongside a DSIP spray made by the method described under DSIP.

Not stated: the amount per dose.

Sources (7)

Not testedOtherFringe

Intranasal epitalon in rats (reference, not a home recipe)

Original source-specific report. Collection checked 30 Sep 2026; presentation annotated 2026-10-01. Source date and reporter identity are not separately verified. Exact form and route are limited to the source’s description.

Ingredients and methodHide the recipe

Ingredients

IngredientAmountRole
Epitalon30 nanograms per ratActive
How it’s used
Single dose in anaesthetised rats.
Sources (2)
Editorial synthesis and reported strength comparison

This synthesized method combines source records. It has not been validated for preparation, sterility, compatibility, absorption or storage. Select a reported strength to inspect the arithmetic; no strength is selected for you.

Not testedNasal spray

No amounts were found in the reviewed recipe records for this one. What was found is under “Original source records”.

Good to know

  • Bacteriostatic water contains 0.9–1.1% benzyl alcohol as a preservative. Its label covers mixing injections, not nasal use; EU labels warn of allergic reactions.
  • Some use store-bought saline nasal spray for its preservatives: often benzalkonium chloride, which can irritate the nose with long use, and sometimes benzyl alcohol.
  • Never tap water: it is not sterile, and CDC researchers warn against it for nasal rinsing.
What people report
Research notes

Doses in circulation differ about 100-fold (100 mcg vs 10 mg a day) and the forums actively dispute them. The 10 mg “Khavinson” figures come from studies of epithalamin (calf pineal extract), not synthetic epitalon (checked in the Russian 2002 paper); the claim that synthetic epitalon is “100 times stronger” and stories of a mistranslation or misplaced decimal point are unverified. “Ukrainian protocol” means different things on different sites (10 mg every 3–4 days vs 5 mg a day for 20 days). The Tailor Made chart row (300 mcg a day, “tendon repair”) looks like a copy error next to its own fact sheet (10 mg every 3 days). Timing advice conflicts (bedtime vs morning). Many dosing pages are AI-written SEO sites; they were avoided except peptides.org, used only for its citation of the International Peptide Society. Regulatory status is in flux after the July 2026 advisory vote.

Nasal spray

The rat study used 30 nanograms per animal; there are no human dose data for nasal epitalon.

What it is. In plain English.

A four-amino-acid “longevity” peptide from Soviet-era research on pineal gland extracts.

A synthetic tetrapeptide designed to mimic epithalamin, an extract of the pineal gland. Developed by Vladimir Khavinson in St. Petersburg.

It’s claimed to switch on telomerase, the enzyme that rebuilds the protective caps on chromosomes, and to restore melatonin rhythms in older animals.

Reviewed 2026-10-01.

Structure. A computed model.

, not measured

Computed 3D model of the tetrapeptide Ala-Glu-Asp-Gly (Epitalon) as balls and sticks: carbon atoms lime green, nitrogen blue, oxygen red.

No experimental structure of Epitalon is in the . This is a computed model of its four amino acids, Ala-Glu-Asp-Gly: a shape calculated from their atoms and bonds. Carbon atoms are lime green, nitrogen blue and oxygen red; hydrogen atoms aren’t drawn. Its formula and bonds were checked against the molecule’s known structure.

Good to know

  • It is one possible shape: a flexible molecule like this one moves and can take others.

PubChem CID 219042. Rendered with Mol* (Sehnal et al., 2021).

Specs. The facts at a glance.

Length
4 amino acids
Sequence
AEDG
Sold as
  • Epitalon 10 mg
Regulatory status
Not an FDA-approved drug. In July 2026 the advisory committee recommended epitalon for possible 503A bulk-list inclusion over FDA staff’s contrary recommendation; FDA had not made a final list decision as of October 1, 2026. The vote is not drug approval.
Also known as
Epithalon; synthetic epithalamin

Sources. What this page rests on.

Every source behind this page, with what it says and when it was checked, is in the Source library.

Epitalon in the Source library

Original overview and research notes · annotated 2026-10-01

Historical collection text. Read alongside the claim corrections above; identity or evidence qualifications may supersede this wording.

Anti-aging (claimed)

A four-amino-acid “longevity” peptide from Soviet-era research on pineal gland extracts.

A synthetic tetrapeptide designed to mimic epithalamin, an extract of the pineal gland. Developed by Vladimir Khavinson in St. Petersburg.

It’s claimed to switch on telomerase, the enzyme that rebuilds the protective caps on chromosomes, and to restore melatonin rhythms in older animals.

Cell studies reported telomere lengthening in human fibroblasts, and rodent studies reported longer lifespans. Nearly all the work comes from the developer’s own group and hasn’t been independently replicated in controlled human trials.

Original status record: Not approved. Research chemical. In July 2026 an FDA advisory panel voted to recommend allowing pharmacies to compound it, against FDA staff advice; the FDA has not decided.

More in Longevity.

Glossary

Protein Data Bank (PDB)

The free worldwide archive of 3D structures of proteins and other molecules measured in experiments. Each entry has a four-character code, like 7KI0.

Glossary

Computed model

A 3D shape calculated by software from a molecule’s atoms and bonds, not measured in an experiment.